Ovarian cancer surgery: does following guidelines save money and improve life quality?

NCT ID NCT02854215

Completed Knowledge-focused Sponsor: Institut Claudius Regaud Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether following national guidelines for ovarian cancer surgery is cost-effective. Researchers measured the cost per quality-adjusted life year (QALY) over three years in 200 women with advanced ovarian cancer. The goal was to understand the economic impact of guideline adherence, not to test a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

fallopian tube cancer ovarian cancer primary peritoneal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

OVARIAN CANCER

Contacts and locations

Locations

Centre Hospitalier Lyon Sud 1

Pierre-Bénite, 69495, France
Centre Hospitalier Lyon Sud 2

Pierre-Bénite, 69495, France
Centre Jean Perrin

Clermont-Ferrand, 63011, France
Chu Clermont Ferrand

Clermont-Ferrand, 63003, France
Hopital Nord-Ouest - Villefranche Sur Saone

Villefranche-sur-Saône, 69655, France
Institut Bergonie

Bordeaux, 33076, France
Institut Claudius Regaud

Toulouse, 31059, France
Institut Curie

Paris, 75248, France
Institut Paoli Calmettes

Marseille, France
Institut Regional Du Cancer Montpellier

Montpellier, 34298, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.